COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.
Trop Med Int Health
; 26(9): 1016-1018, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1266357
ABSTRACT
In addition to the overwhelming and uncontrollable second wave of COVID-19 in India, the country is also dealing with an outbreak of mucormycosis, a deadly fungal infection, which is affecting thousands of COVID-19 patients. With the increasing number of cases of mucormycosis and a fatality rate of 50%, many Indian states and union territories have declared an epidemic of black fungus due to its unprecedented emergence, which has adversely affected the already debilitated health system of the country. The advent of the new fungal epidemic in the country is due to the overdosage, panic and injudicious use of corticosteroids among COVID-19 patients, as well as their pre-existing medical history of diabetes, given that India is the diabetes capital of the world. Thus, there is an urgent need to address this public health concern by having nationwide surveillance, diagnostic and management system of the disease, along with public awareness and education to combat the syndemic of COVID-19 and mucormycosis in the country.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Delivery of Health Care
/
SARS-CoV-2
/
COVID-19
/
Mucormycosis
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
Asia
Language:
English
Journal:
Trop Med Int Health
Journal subject:
Tropical Medicine
/
Public Health
Year:
2021
Document Type:
Article
Affiliation country:
Tmi.13641
Similar
MEDLINE
...
LILACS
LIS